| Market Cap | ₹10,322Cr |
| ROE | 23.64% |
| P/E Ratio(TTM) | 76.78 |
| EPS(TTM) | 8.16 |
| P/B Ratio | 11.51 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.47 |
| Book Value | 54.43 |
| Debt to Equity | 1.10 |
| Face Value | 1 |
| Parent Organisation | Rubicon Research |
| NSE Symbol | RUBICON |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.46 | ||
| Ajanta Pharma | NA (0.00%) | 32.94 | ||
| Gland Pharma | NA (0.00%) | 38.23 | ||
| Eris Lifesciences | NA (0.00%) | 52.18 |